TITLE

THE NEW (6TH EDITION) TNM CLASSIFICATION OF COLORECTAL CANCER--A STAGE TOO FAR

AUTHOR(S)
Howarth, S. M.; Morgan, J. M.; Williams, G. T.
PUB. DATE
April 2004
SOURCE
Gut;Apr2004 Supplement 3, Vol. 53, pA21
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article focuses on the new 6th edition TNM classification of colorectal cancer. The new 6th edition of the TNM staging classification of colorectal cancer changes the histological criteria for interpreting extramural tumour nodules. Changes to TNM staging in the 6th edition have replaced an objective criterion with one that is subjective and not reproducible by pathologists. Application of the new TNM classification "upstages" up to 11% of 13 colorectal cancers. This has implications for patient treatment, clinical trials and cancer intelligence.
ACCESSION #
13218897

 

Related Articles

  • Characteristics of Rectosigmoid Adenomas as Predictors of Synchronous Advanced Proximal Colon Neoplasms. Papatheodoridis, George V.; Triantafyllou, Konstantinos; Tzouvala, Maria; Paspatis, Gregorios; Xourgias, Vassilios; Karamanolis, Demetrios G. // American Journal of Gastroenterology;Sep1996, Vol. 91 Issue 9, p1809 

    Background/Aim: Colonoscopy is recommended to every patient with adenoma in rectosigmoid to disclose synchronous proximal neoplasms. The aim of this study was to determine whether characteristics of rectosigmoid adenomas are associated with proximal advanced neoplasms. Patients/Methods: One...

  • The value of true axial imaging for CT staging of colonic cancer. Anderson, Ewan M.; Betts, Margaret; Slater, Andrew // European Radiology;Jun2011, Vol. 21 Issue 6, p1286 

    Objective: To assess the effect of true axial computed tomography on the accuracy of staging of colonic cancers. Method: Fifty consecutive datasets were independently assessed by three radiologists, experienced in colorectal cancer staging. The first read was of standard axial images only. The...

  • Preoperative computed tomography staging of nonmetastatic colon cancer predicts outcome: implications for clinical trials. Smith, N J; Bees, N; Barbachano, Y; Norman, A R; Swift, R I; Brown, G // British Journal of Cancer;4/10/2007, Vol. 96 Issue 7, p1030 

    Colon cancer patients routinely undergo preoperative computed tomography (CT) scanning, but local staging is thought to be inaccurate. We aimed to determine if clinical outcome could be predicted from radiological features of the primary tumour. Consecutive patients at one hospital undergoing...

  • Redesigning Clinical Trials Necessary to Improve Odds of Finding Effective Targeted Agents in the Genomic Era. Kurzrock, Razelle // Personalized Medicine in Oncology;Nov2013, Vol. 2 Issue 7, p366 

    Information on advances in tumor biomarkers and their use in managing tumors and hematologic malignancies discussed at the 2013 Global Biomarkers Consortium conference is presented. A patient-centric approach in clinical trial design in oncology will be required in determining optimal...

  • Anti-tumor activity of a novel monoclonal antibody, NPC-1C, optimized for recognition of tumor antigen MUC5AC variant in preclinical models. Patel, Sandip; Bristol, Andrew; Saric, Olga; Wang, Xue-Ping; Dubeykovskiy, Alex; Arlen, Philip; Morse, Michael // Cancer Immunology, Immunotherapy;Jun2013, Vol. 62 Issue 6, p1011 

    Purpose: NPC-1C is a chimeric immunoglobulin IgG1 developed from antigen tested in the Hollinshead tumor vaccine trials that recognizes an immunogenic MUC5AC-related tumor-associated antigen. In this article, we describe the pre-clinical characterization of this antibody that is currently being...

  • Folate and Cancer--Timing Is Everything. Ulrich, Cornelia M.; Potter, John D. // JAMA: Journal of the American Medical Association;6/6/2007, Vol. 297 Issue 21, p2408 

    This article presents an editorial on folate supplementation and cancer prevention. Studies are showing that the role of folate in cancer prevention may not be straight forward. The author says the timing of folate administration seems to be key to its effectiveness. Folate administration prior...

  • The effect of chemotherapy combined with recombination mutant human tumor necrosis factor on advanced cancer. Xing Liu; Xiang-fu Zhang; Zhi-weng Zheng; Huishan Lu; Xinyuan Wu; Changmin Huang; Chuan Wang; Guoxiang Guang // Journal of Translational Medicine;2004, Vol. 2, p33 

    Background: Past studies suggested that tumor necrosis factor (TNF) assisted anti-tumor treatment and intensified the sensitivity of chemotherapy. However its clinical application has been curbed because of its low purity, high dosage, and strong toxicity. This research, through perspective...

  • selenium for the colon.  // Better Nutrition;Feb2005, Vol. 67 Issue 2, p17 

    This article reports information related to role of selenium in lowering risk of colon cancer. A higher level of the mineral selenium in the blood is now linked to a decreased risk of colorectal cancer. Researchers conducted a pooled analysis a study in which information collected from three...

  • MORPHOCLINICAL OBSERVATIONS IN COLORECTAL CARCINOMA. POPA, DRAGOŞ; GURZU, SIMONA; STOICA, IOAN; OLÂH, PETER; VOIDĂZAN, SEPTIMIU; COROŞ, FLORIN // Acta Medica Transilvanica;mar2013, Vol. 18 Issue 1, p272 

    Introduction: Colorectal cancer is one of the most present neoplastic diseases of the digestive tract and requires constant study of factors that can be influenced to improve patient prognosis. Material and methods: In this study, we focused on selecting the patients who benefited from surgical...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics